Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer

Irshad, S.; Gillett, C.; Pinder, S. E.; Dowsett, M.; Ellis, I. O.; Bartlett, J. M. S.; Bliss, J. M.; Hanby, A.; Johnston, S.; Barrett-Lee, P.; Tutt, A.; Ellis, P

doi:10.1007/s10549-014-2855-4

Research Repository

Advanced Search

Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer

Authors

S. Irshad

C. Gillett

S. E. Pinder

R. P.

M. Dowsett

Professor IAN ELLIS IAN.ELLIS@NOTTINGHAM.AC.UK
Professor of Cancer Pathology

J. M. S. Bartlett

J. M. Bliss

A. Hanby

S. Johnston

P. Barrett-Lee

A. Tutt

P Ellis

Citation

Irshad, S., Gillett, C., Pinder, S. E., A’Hern, R. P., Dowsett, M., Ellis, I. O., …Ellis, P. (2014). Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer. Breast Cancer Research and Treatment, 144(2), 331-341. https://doi.org/10.1007/s10549-014-2855-4

Journal Article Type	Article
Acceptance Date	Jan 22, 2014
Online Publication Date	Feb 12, 2014
Publication Date	2014-04
Deposit Date	Dec 6, 2018
Journal	Breast Cancer Research and Treatment
Print ISSN	0167-6806
Electronic ISSN	1573-7217
Publisher	Springer Verlag
Peer Reviewed	Peer Reviewed
Volume	144
Issue	2
Pages	331-341
DOI	https://doi.org/10.1007/s10549-014-2855-4
Public URL	https://nottingham-repository.worktribe.com/output/1370383
Publisher URL	https://link.springer.com/article/10.1007%2Fs10549-014-2855-4